Elsevier's Maturitas Publishes Position Statement on Menopause for Medical Students
Amsterdam, March 20, 2014
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on the topic of the essential menopause curriculum for medical students.
The menopause, or the cessation of the menstrual cycle, is the result of ovarian aging and is a natural event experienced by most women in their late 40s or early 50s. With increasing longevity the menopause can now be considered to be a midlife event. Thus managing postmenopausal health is a key issue for all health professionals, not just gynaecologists.
Discussions with patients about the menopause are becoming more complex because of women’s increasing longevity, the wide range of therapeutic options, the controversies regarding menopausal hormone therapy and the increasing use of alternative and complementary therapies. The published position statement provides guidance in bullet-point style on the essential issues that medical students need to know about the stages of reproductive aging, menopause terminology, menopause and postmenopausal health. Management strategies should be holistic and include diet and lifestyle, menopausal hormone therapy, non-estrogen based treatments for menopausal symptoms and osteoporosis and alternative and complementary therapies. The treatment of choice for premature menopause is menopausal hormone therapy until the average age of the natural menopause (i.e. late 40s early 50s).
These and other recommendations presented in EMAS’ position statement are published in the article: “EMAS Position statement: Menopause for medical students” by Janet Brockie, Irene Lambrinoudaki, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Faustino R. Pérez-López, Karin Schenck-Gustafsson, Yvonne van der Schouw, Tommaso Simoncini, Florence Tremollieres and Margaret Rees.
The article appears in Maturitas (doi:10.1016/j.maturitas.2014.02.007) and is available on ScienceDirect.
About European Menopause and Andropause Society (EMAS)
Using a range of activities and through its affiliates, EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders. Recognizing the issues arising from increased longevity the society also provides articles, patient information, web resources, and referrals for healthcare providers in the field and keeps its members up-to-date.
For more information go to: http://www.emas-online.org/
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com
+31 20 485 3323